Biocept: Rises on supply deal for COVID-19 test kit

Biocept

02/03/2021 14:27

** Molecular diagnostics co's  BIOC.O  shares rise 11.4% to
$7.20 premarket
    ** Co and Aegea Biotechnologies enter into supply agreement
for new COVID-19 test that can distinguish between virus strains
and quantify viral load  urn:newsml:reuters.com:*:nBw3WHMlga
    ** The deal is for a new PCR-based COVID-19 kit designed by
Aegea and co-developed by the cos
    ** Under agreement, BIOC will partner with Aegea to validate
and commercialize the COVID-19 assay kit - Aegea
    ** Up to last close, BIOC stock up ~45% YTD

 (Reporting by Vishwadha Chander in Bengaluru)
 ((Vishwadha.Chander@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 80 6749 6132;))